Tirofiban After Successful MT Recanalization in AIS

NCT06265051 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 1380

Last updated 2026-03-11

No results posted yet for this study

Summary

Acute ischemic stroke with large vessel occlusion is a frequently occurring life-threatening condition. Although endovascular treatment can effectively open occluded vessels, the successful reperfusion rate exceeds 80%, but the rate of good prognosis is less than 50%. The current clinical focus is on how to improve futile recanalization. Tirofiban is widely used in the treatment of stroke, as it can effectively prevent vascular reocclusion and improve microcirculation perfusion. It has the potential to improve futile recanalization, but there is a lack of high-level evidence-based medical support. This multicenter, prospective, double-blind, randomized controlled trial was conducted to assess the effectiveness and safety of sequential tirofiban therapy following successful mechanical thrombectomy within 24 hours of onset.

Conditions

  • Acute Ischemic Stroke
  • Vessel Occlusion

Interventions

DRUG

Tirofiban

After the completion of endovascular treatment and successful recanalization (mTICI 2b/3), the patients were randomly assigned to the experimental group. Tirofiban 5μg/kg was administered intravenously through the catheter artery at a rate of 1ml/min, followed by an intravenous infusion of 0.1μg/(kg·min) for 24 hours. Standard medical treatment was administered after the surgery.

DRUG

Saline placebo

After the completion of endovascular treatment and successful recanalization (mTICI 2b/3), the patients were randomly assigned to the experimental group. Saline placebo was administered in the same manner as tirofiban group. Standard medical treatment was administered after the surgery.

Sponsors & Collaborators

  • Fujian Medical University Union Hospital

    collaborator OTHER
  • Jingzhou Hospital Affiliated to Yangtze University

    collaborator UNKNOWN
  • Xiangyang No 1 People's Hospital Affiliated to Hubei University of Medicine

    collaborator UNKNOWN
  • Puren Hospital Affiliated to Wuhan University of Science and Technology

    collaborator OTHER
  • Zhongnan Hospital

    collaborator OTHER
  • First Affiliated Hospital of Fujian Medical University

    collaborator OTHER
  • Huazhong University of Science and Technology Tongji Medical College Affiliated Wuhan Central Hospital

    collaborator UNKNOWN
  • Xianning Central Hospital

    collaborator OTHER
  • Shanxi Provincial People's Hospital

    collaborator OTHER_GOV
  • The Third People's Hospital of Hubei Province

    collaborator OTHER
  • Jingmen Central Hospital

    collaborator UNKNOWN
  • Hubei University of Medicine

    collaborator OTHER
  • Wuhan No.1 Hospital

    collaborator OTHER
  • Nanyang Central Hospital

    collaborator OTHER
  • Yichang Central People's Hospital of China Three Gorges University

    collaborator UNKNOWN
  • The Central Hospital of Huanggang

    collaborator OTHER
  • Zoucheng City People's Hospital

    collaborator UNKNOWN
  • Qujing Central Hospital of Yunnan Province

    collaborator UNKNOWN
  • Taihe Hospital, Affiliated Hospital of Hubei Province of Medicine

    collaborator UNKNOWN
  • Second Affiliated Hospital of Soochow University

    collaborator OTHER
  • The First Affiliated Hospital of Nanchang University

    collaborator OTHER
  • Central Hospital of Xiaogan

    collaborator OTHER
  • The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture

    collaborator OTHER
  • Huangshi Central Hospital

    collaborator OTHER
  • Zigong No.1 Peoples Hospital

    collaborator OTHER
  • Xiangyang Hospital of Traditional Chinese Medicine

    collaborator UNKNOWN
  • The First People's Hospital of Jingzhou City

    collaborator UNKNOWN
  • The First people's hospital of Xian Yang

    collaborator UNKNOWN
  • Jiujiang No.1 People's Hospital

    collaborator OTHER
  • Zhongxiang Hospital of Traditional Chinese Medicine

    collaborator UNKNOWN
  • Jiangxi Provincial People's Hopital

    collaborator OTHER
  • The Lichuan ethnic Hospital of Traditional Chinese Medicine

    collaborator UNKNOWN
  • Xiangyang Central Hospital People's Hospital of Huangpi District

    collaborator UNKNOWN
  • Quanzhou First Hospital

    collaborator OTHER
  • Minda Hospital of Hubei Minzu University

    collaborator UNKNOWN
  • The Cerebrovascular Hospital of Hubei Province

    collaborator UNKNOWN
  • The First People's Hospital of Changde City

    collaborator OTHER
  • Longyan First Affiliated Hospital of Fujian Medical University

    collaborator UNKNOWN
  • Xiangzhou People's Hospital

    collaborator UNKNOWN
  • Jingmen People's Hospital

    collaborator UNKNOWN
  • The First People's Hospital of TianMen in Hubei Province

    collaborator UNKNOWN
  • Hanyang Hospital, Wuhan University of Science & Technology

    collaborator UNKNOWN
  • Tongcheng People's Hospital

    collaborator UNKNOWN
  • Gaoyou People's Hospital

    collaborator UNKNOWN
  • Zaoyang First People's Hospital

    collaborator UNKNOWN
  • CR & WISCO General Hospital

    collaborator UNKNOWN
  • Wuhan Hankou Hospital

    collaborator UNKNOWN
  • Lu'an People's Hospital of Anhui Hospital

    collaborator UNKNOWN
  • Yingtan People's Hospital

    collaborator UNKNOWN
  • Shiyan Renmin Hospital

    collaborator UNKNOWN
  • Dali Bai Autonomous Prefecture People's Hospital

    collaborator UNKNOWN
  • Three Gorges Hospital of Chongqing University

    collaborator OTHER
  • The Second People's Hospital of Jingzhou City

    collaborator UNKNOWN
  • General Hospital of the Yangtze River Shipping

    collaborator UNKNOWN
  • The Affiliated Hospital Of Southwest Medical University

    collaborator OTHER
  • Fujian Provincial Hospital

    collaborator OTHER
  • Zhongxiang People's Hospital

    collaborator UNKNOWN
  • LiuZhou People's Hospital

    collaborator OTHER
  • The Fifth Hospital of Wuhan

    collaborator OTHER
  • Xiaogan First People's Hospital

    collaborator UNKNOWN
  • Loudi Central Hospital

    collaborator OTHER
  • Ezhou Central Hospital

    collaborator UNKNOWN
  • Second Xiangya Hospital of Central South University

    collaborator OTHER
  • Qingdao Central Hospital

    collaborator OTHER
  • Taizhou First People's Hospital

    collaborator OTHER
  • Renmin Hospital of Wuhan University

    collaborator OTHER
  • Hubei Provincial Hospital of Integrated Chinese & Western Medicine

    collaborator UNKNOWN
  • The First Affiliated Hospital of Botou Medical College

    collaborator UNKNOWN
  • Xianfeng People's Hospital

    collaborator UNKNOWN
  • Wuhan Third Hospital

    collaborator OTHER
  • The Fourth Hospital of Wuhan

    collaborator UNKNOWN
  • Chengdu Fifth People's Hospital

    collaborator OTHER
  • Xingyi People's Hospital

    collaborator UNKNOWN
  • Affiliated Hospital of Shandong University of Traditional Chinese Medicine

    collaborator OTHER
  • Shenzhen Hospital of Southern Medical University

    collaborator OTHER
  • The Third People's Hospital of Jingzhou City

    collaborator UNKNOWN
  • The First People's Hospital of Jiangxia District

    collaborator UNKNOWN
  • Xihua People's Hospital

    collaborator UNKNOWN
  • Shanghai East Hospital

    collaborator OTHER
  • Xiang Luo

    lead OTHER

Principal Investigators

  • Xiang Luo · Tongji Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-09
Primary Completion
2025-12-29
Completion
2025-12-29

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06265051 on ClinicalTrials.gov